Sign up for your FREE personalized newsletter featuring insights, trends, and news for America's Active Baby Boomers

Newsletter
New

Why Hims & Hers Health Stock Popped 17.1% Today

Card image cap

Shares of growth stock Hims & Hers Health (NYSE: HIMS) jumped as much as 17.1% in trading on Tuesday after the company reported first-quarter 2024 financial results. As of 3 p.m. ET, shares were holding about an 8.4% gain for the day.

Crushing expectations

Hims & Hers said revenue for the quarter jumped 46% from a year ago to $278.2 million and sailed past the $268.7 million that analysts were expecting. The company also reported net income of $11.1 million, or $0.05 per share on an adjusted basis, topping Wall Street estimates of $0.01 in earnings per share.

Management said the number of subscribers jumped 41% from a year ago to 1.7 million people and revenue per subscriber stayed flat at $55. New product launches have helped grow the opportunity, but clearly, the core value proposition is working for Hims & Hers.

A big year ahead

Management also said 2024 revenue would grow between 38% and 41% to $1.20 billion to $1.23 billion. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) is expected to increase 10% to 11% to between $120 million and $135 million. That's a solid value for a company currently worth $2.7 billion, given the growth rate.

Investors have long questioned whether Hims & Hers growth is sustainable, given potentially high churn and high customer acquisition costs. But the model continues to work and, as it does, investors put more value on the company's growth. I think the market's reaction as the day wore on is starting to create a buying opportunity for long-term investors looking at a growth stock in healthcare.

Should you invest $1,000 in Hims & Hers Health right now?

Before you buy stock in Hims & Hers Health, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $564,547!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of May 6, 2024

Travis Hoium has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.